Ossami Saidy, R.R.; Wegener, E.; Uluk, D.; Dittrich, L.; Schöning, W.; Lurje, G.; Öllinger, R.; Modest, D.P.; Tacke, F.; Haase, O.;
et al. A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation. Medicina 2022, 58, 1755.
https://doi.org/10.3390/medicina58121755
AMA Style
Ossami Saidy RR, Wegener E, Uluk D, Dittrich L, Schöning W, Lurje G, Öllinger R, Modest DP, Tacke F, Haase O,
et al. A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation. Medicina. 2022; 58(12):1755.
https://doi.org/10.3390/medicina58121755
Chicago/Turabian Style
Ossami Saidy, Ramin Raul, Elisa Wegener, Deniz Uluk, Luca Dittrich, Wenzel Schöning, Georg Lurje, Robert Öllinger, Dominik Paul Modest, Frank Tacke, Oliver Haase,
and et al. 2022. "A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation" Medicina 58, no. 12: 1755.
https://doi.org/10.3390/medicina58121755
APA Style
Ossami Saidy, R. R., Wegener, E., Uluk, D., Dittrich, L., Schöning, W., Lurje, G., Öllinger, R., Modest, D. P., Tacke, F., Haase, O., Pratschke, J., & Eurich, D.
(2022). A Reduction of Calcineurin Inhibitors May Improve Survival in Patients with De Novo Colorectal Cancer after Liver Transplantation. Medicina, 58(12), 1755.
https://doi.org/10.3390/medicina58121755